Researchers examined the efficacy and safety of lower doses of an insulin-sensitizing drug in adults with prior stroke or transient ischemic attacks who have insulin resistance.
In this COVID-19 roundup, we discuss the FDA approval of an additional COVID-19 booster dose in certain populations, the latest FDA update on emergency use of sotrovimab, and cognitive impairment...
The American Heart Association and the American Stroke Association have released new guidelines on poststroke management of adults in the primary care setting.
New data presented at the Alzheimer’s Association International Conference indicate that measuring levels of this biomarker in plasma and cerebrospinal fluid can detect Alzheimer disease with high...
In a study of nearly 1.5 million people, researchers aimed to determine the impact of infections on the risk of mortality among people with or without dementia. The findings were presented at the...
Influenza vaccination may be a “promising, readily available candidate” for the prevention of Alzheimer disease, according to new findings presented at the Alzheimer’s Association International Conference.
...
Despite known, independent associations of hearing loss and vision loss with dementia, less is known about the relationship between dual sensory impairment and dementia risk. Researchers aimed to assess...
The FDA has approved a drug therapy to treat seizures associated with Dravet syndrome–a chronic, rare, and life-threatening form of epilepsy–among patients aged 2 years or older.
